United States· US:68982-954_ffbb7ae1-5bc6-ce20-c70d-80b8453f34d3
Octaplas
A medicinal product containing plasma protein fraction (human), registered in United States by Octapharma USA Inc.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- PLASMA PROTEIN FRACTION (HUMAN)
- Manufacturer
- Octapharma USA Inc
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 2
- ndc116898295401200 mL in 1 BAG (68982-954-01)
- ndc1168982-954-01
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Plasma protein fraction (human) in 12 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SwitzerlandBerinert IV
- SpainOCTAPLASMALG (0) 45-70 MG/ML POLVO Y DISOLVENTE PARA SOLUCION PARA PERFUSIONOctapharma S.A.
- CzechiaCYMVIGOBiotest Pharma GmbH, Dreieich
- United KingdomOctaplas 11.5g/200ml infusion bagsOctapharma Ltd
- GermanyAlbumeonCsl Behring Gmbh
- BelgiumIntratect 50 g/lBiotest Pharma
- IrelandFlexbumin 200 g/l solution for infusionBaxalta Innovations GmbH
- NorwayAlburexCSL Behring GmbH
Authorised across Europe · EMA
The same active substance is authorised in 30 EEA countries. Names it is sold under:
- Austria · Albunorm, Alburex
- Belgium · Alburex, Human Albumin Csl Behring
- Bulgaria · Албурекс, Октапласlg
- Cyprus · Albumeon, Alburex
- Czechia · Alburex, Human Albumin Csl Behring
- Germany · Albumeon, Albunorm
- Denmark · Albumin Behring, Albunorm
- Estonia · Human Albumin Csl Behring, Octaplaslg
- Spain · Albúmina Humana Csl Behring, Albunorm
- Finland · Albumin Behring, Albunorm
- France · Albumine Humaine Csl Behring, Albunorm
- United Kingdom (Northern Ireland) · Albumeon, Alburex
- Greece · Albumeon, Alburex
- Croatia · Albumeon, Albunorm
- Hungary · Alburex, Human Albumin Csl Behring
- Ireland · Alburex, Human Albumin Csl Behring
- Iceland · Albumin Behring, Albunorm
- Italy · Albumeon, Albunorm
- Lithuania · Human Albumin Csl Behring, Octaplasma
- Luxembourg · Alburex, Human Albumin Csl Behring
- Latvia · Human Albumin Csl Behring, Octaplasma
- Malta · Albumeon, Alburex
- Netherlands · Albunorm, Alburex
- Norway · Albumin Behring, Albunorm
- Poland · Alburex, Human Albumin Csl Behring
- Portugal · Albumina Humana Csl Behring, Alburex
- Romania · Albumeon, Alburex
- Sweden · Albumin Behring, Albunorm
- Slovenia · Alburex, Humani Albumin Csl Behring
- Slovakia · Alburex, Human Albumin Csl Behring
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/3f2b8627-6bc8-474d-a3cc-f6b8a0f24081 GET /v1/drugs/3f2b8627-6bc8-474d-a3cc-f6b8a0f24081?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "INTRAVENOUS",
"source": "ndc",
"strength": "11.5",
"substance": "PLASMA PROTEIN FRACTION (HUMAN)",
"productndc": "68982-954",
"dosage_form": "SOLUTION",
"dea_schedule": null,
"strength_unit": "g/200mL",
"application_number": "BLA125416",
"marketing_category": "BLA"
}See everything about plasma protein fraction (human).
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.